Studying ischemic preconditioning in isolated cardiomyocyte models

Cardiovascular Research

Volumn 70, Issue 2, 2006, Pages 286-296

  Diaz, Roberto J ^a   Wilson, Gregory J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cardiomyocytes; Cell culture; Ischemic preconditioning; Simulated ischemia reperfusion

Indexed keywords

AMOBARBITAL; CHLORIDE CHANNEL; CYCLOSPORIN A; DIAZOXIDE; DYE; EGTAZIC ACID; ETHIDIUM BROMIDE; GLUCOSE; LACTIC ACID; NICORANDIL; POTASSIUM CHANNEL; PROPIDIUM IODIDE; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE;

CELL CULTURE; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CHICK; ENZYME RELEASE; GENE EXPRESSION; GENETIC MANIPULATION; GLYCOGENOLYSIS; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HYPERKALEMIA; HYPOXIA; ISCHEMIC PRECONDITIONING; NICK END LABELING; NONHUMAN; OSMOTIC FRAGILITY; PRIORITY JOURNAL; RAT STRAIN; REPERFUSION INJURY; REVIEW; SIMULATION; VIRUS RECOMBINANT;

ADULT; ANIMALS; CELLS, CULTURED; HEART; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; RESEARCH DESIGN;

EID: 33748266891     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.12.003     Document Type: Review

References (88)

1. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
2. Baxter G.F., and Yellon D.M. Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?. Br J Clin Pharmacol 38 (1994) 381-387
3. Yellon D.M., and Baxter G.F. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?. J Mol Cell Cardiol 27 (1995) 1023-1034
4. Przyklenk K., Darling C.E., Dickson E.W., and Whittaker P. Cardioprotection 'outside the box'-the evolving paradigm of remote preconditioning. Basic Res Cardiol 98 (2003) 149-157
5. Fryer R.M., Auchampach J.A., and Gross G.J. Therapeutic receptor targets of ischemic preconditioning. Cardiovasc Res 55 (2002) 520-525
6. Ping P., Zhang J., Qiu Y., Tang X.L., Manchikalapudi S., Cao X., et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81 (1997) 404-414
7. Liu H., McPherson B.C., and Yao Z. Preconditioning attenuates apoptosis and necrosis: role of protein kinase C epsilon and -delta isoforms. Am J Physiol Heart Circ Physiol 281 (2001) H404-H410
8. Meldrum D.R., Cleveland Jr. J.C., Meng X., Sheridan B.C., Gamboni F., Cain B.S., et al. Protein kinase C isoform diversity in preconditioning. J Surg Res 69 (1997) 183-187
9. Armstrong S.C. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61 (2004) 427-436
10. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 (2003) 1113-1151
11. Sandhu R., Diaz R.J., Mao G.D., and Wilson G.J. Ischemic preconditioning: differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation 96 (1997) 984-995
12. Fryer R.M., Schultz J.E., Hsu A.K., and Gross G.J. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol 276 (1999) H1229-H1235
13. Tanno M., Tsudisha A., Nozawa Y., Matsumoto T., Hasegawa T., Miura T., et al. Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat. J Cardiovasc Pharmacol 35 (2000) 345-352
14. Vahlhaus C., Schulz R., Post H., Rose J., and Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol 30 (1998) 197-209
15. Patel H.H., Gross E.R., Peart J.N., Hsu A.K., and Gross G.J. Sarcolemmal KATP channel triggers delayed ischemic preconditioning in rats. Am J Physiol Heart Circ Physiol 288 (2005) H445-H447
16. Rainbow R.D., Lodwick D., Hudman D., Davies N.W., Norman R.I., and Standen N.B. SUR2A C-terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes. J Physiol 557 (2004) 785-794
17. Suzuki M., Sasaki N., Miki T., Sakamoto N., Ohmoto-Sekine Y., Tamagawa M., et al. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 109 (2002) 509-516
18. Diaz R.J., Losito V.A., Mao G.D., Ford M.K., Backx P.H., and Wilson G.J. Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium. Circ Res 84 (1999) 763-775
19. Batthish M., Diaz R.J., Zeng H.P., Backx P.H., and Wilson G.J. Pharmacological preconditioning in rabbit myocardium is blocked by chloride channel inhibition. Cardiovasc Res 55 (2002) 660-671
20. Diaz R.J., Armstrong S.C., Batthish M., Backx P.H., Ganote C.E., and Wilson G.J. Enhanced cell volume regulation: a key protective mechanism of ischemic preconditioning in rabbit ventricular myocytes. J Mol Cell Cardiol 35 (2003) 45-58
21. Chen H., Liu L.L., Ye L.L., McGuckin C., Tamowski S., Scowen P., et al. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart. Circulation 110 (2004) 700-704
22. Diaz R.J., Zobel C., Cho H.C., Batthish M., Hinek A., Backx P.H., et al. Selective inhibition of inward rectifier K+ channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes. Circ Res 95 (2004) 325-332
23. Schwanke U., Konietzka I., Duschin A., Li X., Schulz R., and Heusch G. No ischemic preconditioning in heterozygous connexin 43-deficient mice. Am J Physiol Heart Circ Physiol 283 (2002) H1740-H1742
24. O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res 94 (2004) 420-432
25. Hausenloy D.J., Maddock H.L., Baxter G.F., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc Res 55 (2002) 534-543
26. Javadov S.A., Clarke S., Das M., Griffiths E.J., Lim K.H., and Halestrap A.P. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549 (2003) 513-524
27. Piper H.M., Garcia-Dorado D., and Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 38 (1998) 291-300
28. Piper H.M., Meuter K., and Schafer C. Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 75 (2003) S644-S648
29. Armstrong S., and Ganote C.E. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia. Cardiovasc Res 28 (1994) 1700-1706
30. Armstrong S., Downey J.M., and Ganote C.E. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 28 (1994) 72-77
31. Ikonomidis J.S., Tumiati L.C., Weisel R.D., Mickle D.A., and Li R.K. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res 28 (1994) 1285-1291
32. Vander Heide R.S., Rim D., Hohl C.M., and Ganote C.E. An in vitro model of myocardial ischemia utilizing isolated adult rat myocytes. J Mol Cell Cardiol 22 (1990) 165-181
33. Altschuld R.A., Hostetler J.R., and Brierley G.P. Response of isolated rat heart cells to hypoxia, re-oxygenation, and acidosis. Circ Res 49 (1981) 307-316
34. Altschuld R., Gibb L., Ansel A., Hohl C., Kruger F.A., and Brierley G.P. Calcium tolerance of isolated rat heart cells. J Mol Cell Cardiol 12 (1980) 1383-1395
35. Rim D.S., and Ganote R.A. Effects of calcium depletion and loading on injury during metabolic inhibition of isolated adult rat myocytes. J Mol Cell Cardiol 22 (1990) 227-237
36. Ganote C.E., Armstrong S., and Downey J.M. Adenosine and A1 selective agonists offer minimal protection against ischaemic injury to isolated rat cardiomyocytes. Cardiovasc Res 27 (1993) 1670-1676
37. Liu G.S., Cohen M.V., Mochly-Rosen D., and Downey J.M. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31 (1999) 1937-1948
38. Safran N., Shneyvays V., Balas N., Jacobson K.A., Nawrath H., and Shainberg A. Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol Cell Biochem 217 (2001) 143-152
39. Tsouka V., Markou T., and Lazou A. Differential effect of ischemic and pharmacological preconditioning on PKC isoform translocation in adult rat cardiac myocytes. Cell Physiol Biochem 12 (2002) 315-324
40. Wilson G., Omar S., and Diaz R. Ultrastructural changes due to simulated ischemia and simulated reperfusion in ventricular myocytes. J Mol Cell Cardiol 30 (1998) A16
41. Armstrong S.C., and Ganote C.E. Effects of phosphatase inhibitor mepacrine on injury in ischemic and metabolically inhibited adult isolated myocytes. Am J Pathol 138 (1991) 545-555
42. Armstrong S., and Ganote C.E. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Cardiovasc Res 28 (1994) 1049-1056
43. Armstrong S., and Ganote C.E. In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: effects of selective adenosine receptor blockade and calphostin C. Cardiovasc Res 29 (1995) 647-652
44. Armstrong S.C., Kao R., Gao W., Shivell L.C., Downey J.M., Honkanen R.E., et al. Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: effects of a protein phosphatase inhibitor, fostriecin. J Mol Cell Cardiol 29 (1997) 3009-3024
45. Armstrong S.C., Hoover D.B., Shivell L.C., and Ganote C.E. Preconditioning of isolated rabbit cardiomyocytes: no evident separation of induction, memory and protection. J Mol Cell Cardiol 29 (1997) 2285-2298
46. Armstrong S.C., Shivell L.C., Kao R., Downey J.M., and Ganote C.E. Pig cardiomyocytes precondition in vitro: role for KATP channels and metabolic rate. J Mol Cell Cardiol 29 (1997) A227 (Abstract)
47. Wang J., Drake L., Sajjadi F., Firestein G.S., Mullane K.M., and Bullough D.A. Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes. Eur J Pharmacol 320 (1997) 241-248
48. Liu Y., Sato T., O'Rourke B., and Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?. Circulation 97 (1998) 2463-2469
49. Liu G.S., Cohen M.V., Mochly-Rosen D., and Downey J.M. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31 (1999) 1937-1948
50. Takasaki Y., Wolff R.A., Chien G.L., and van Winkle D.M. Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta-opioid receptors. Am J Physiol 277 (1999) H2442-H2450
51. Cao Z., Liu L., and Van Winkle D.M. Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am J Physiol Heart Circ Physiol 285 (2003) H1032-H1039
52. Budas G.R., Jovanovic S., Crawford R.M., and Jovanovic A. Hypoxia-induced preconditioning in adult stimulated cardiomyocytes is mediated by the opening and trafficking of sarcolemmal KATP channels. Faseb J. 18 (2004) 1046-1048
53. Smith R.M., Suleman N., Lacerda L., Opie L.H., Akira S., Chien K.R., et al. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res 63 (2004) 611-616
54. Strijdom H., Genade S., and Lochner A. Nitric oxide synthase (NOS) does not contribute to simulated ischaemic preconditioning in an isolated rat cardiomyocyte model. Cardiovasc Drugs Ther 18 (2004) 99-112
55. Li X., Heinzel F.R., Boengler K., Schulz R., and Heusch G. Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J Mol Cell Cardiol 36 (2004) 161-163
56. Ikonomidis J.S., Shirai T., Weisel R.D., Derylo B., Rao V., Whiteside C.I., et al. "Ischemic" or adenosine preconditioning of human ventricular cardiomyocytes is protein kinase C dependent. Circ Res 92 (1995) I12 (Abstract)
57. Strickler J., Jacobson K.A., and Liang B.T. Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors. J Clin Invest 98 (1996) 1773-1779
58. Liang B.T. Direct preconditioning of cardiac ventricular myocytes via adenosine A1 receptor and KATP channel. Am J Physiol 271 (1996) H1769-H1777
59. Liang B.T. Protein kinase C-mediated preconditioning of cardiac myocytes: role of adenosine receptor and KATP channel. Am J Physiol 273 (1997) H847-H853
60. Liang B.T., and Jacobson K.A. A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc Natl Acad Sci U S A 95 (1998) 6995-6999
61. Liang B.T., and Gross G.J. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 84 (1999) 1396-1400
62. Gray M.O., Karliner J.S., and Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 272 (1997) 30945-30951
63. Arstall M.A., Zhao Y.Z., Hornberger L., Kennedy S.P., Buchholz R.A., Osathanondh R., et al. Human ventricular myocytes in vitro exhibit both early and delayed preconditioning responses to simulated ischemia. J Mol Cell Cardiol 30 (1998) 1019-1025
64. Dougherty C., Barucha J., Schofield P.R., Jacobson K.A., and Liang B.T. Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor. Faseb J 12 (1998) 1785-1792
65. Vanden Hoek T., Becker L.B., Shao Z.H., Li C.Q., and Schumacker P.T. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 86 (2000) 541-548
66. Karliner J.S., Honbo N., Epstein C.J., Xian M., Lau Y.F., and Gray M.O. Neonatal mouse cardiac myocytes exhibit cardioprotection induced by hypoxic and pharmacologic preconditioning and by transgenic overexpression of human Cu/Zn superoxide dismutase. J Mol Cell Cardiol 32 (2000) 1779-1786
67. Date T., Belanger A.J., Mochizuki S., Sullivan J.A., Liu L.X., Scaria A., et al. Adenovirus-mediated expression of p35 prevents hypoxia/reoxygenation injury by reducing reactive oxygen species and caspase activity. Cardiovasc Res 55 (2002) 309-319
68. Date T., Mochizuki S., Belanger A.J., Yamakawa M., Luo Z., Vincent K.A., et al. Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. Am J Physiol Cell Physiol 288 (2005) C314-C320
69. Lebuffe G., Schumacker P.T., Shao Z.H., Anderson T., Iwase H., and Vanden Hoek T.L. ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. Am J Physiol Heart Circ Physiol 284 (2003) H299-H308
70. Uchiyama T., Engelman R.M., Maulik N., and Das D.K. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation 109 (2004) 3042-3049
71. Hausenloy D.J., Yellon D.M., Mani-Babu S., and Duchen M.R. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 287 (2004) H841-H849
72. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113 (2004) 1535-1549
73. Trump B.F., Berezesky I.K., Chang S.H., and Phelps P.C. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol 25 (1997) 82-88
74. Elsässer A., Suzuki K., Lorenz-Meyer S., Bode C., and Schaper J. The role of apoptosis in myocardial ischemia: a critical appraisal. Basic Res Cardiol 96 (2001) 219-226
75. Ohno M., Takemura G., Ohno A., Misao J., Hayakawa Y., Minatoguchi S., et al. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation 98 (1998) 1422-1430
76. Oldenburg O., Critz S.D., Cohen M.V., and Downey J.M. Acetylcholine-induced production of reactive oxygen species in adult rabbit ventricular myocytes is dependent on phosphatidylinositol 3- and Src-kinase activation and mitochondrial K(ATP) channel opening. J Mol Cell Cardiol 35 (2003) 653-660
77. Schwanke U., Li X., Schulz R., and Heusch G. No ischemic preconditioning in heterozygous connexin 43-deficient mice-a further in vivo study. Basic Res Cardiol 98 (2003) 181-182
78. Ping P., Zhang J., Cao X., Li R.C., Kong D., Tang X.L., et al. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Adv Physiol Educ 276 (1999) H1468-H1481
79. Li R.C., Ping P., Zhang J., Wead W.B., Cao X., Gao J., et al. PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 279 (2000) H1679-H1689
80. Zobel C., Cho H.C., Nguyen T.T., Pekhletski R., Diaz R.J., Wilson G.J., et al. Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric co-assembly of Kir2.1 and Kir2.2. J Physiol 550 (2003) 365-372
81. Diaz R.J., and Wilson G.J. Modifying the first minute of reperfusion: potential for myocardial salvage. Cardiovasc Res 62 (2004) 4-6
82. Veldkamp M.W., de Jonge B., and van Ginneken A.C. Decreased inward rectifier current in adult rabbit ventricular myocytes maintained in primary culture: a single-channel study. Cardiovasc Res 42 (1999) 424-433
83. Hanley P.J., and Daut J. K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. J Mol Cell Cardiol 39 (2005) 17-50
84. Weiss J.N., Korge P., Honda H.M., and Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 93 (2003) 292-301
85. Ardehali H., and O'Rourke B. Mitochondrial K(ATP) channels in cell survival and death. J Mol Cell Cardiol 39 (2005) 7-16
86. Garlid K.D., and Paucek P. Mitochondrial potassium transport: the K(+) cycle. Biochim Biophys Acta 1606 (2003) 23-41
87. Vondriska T.M., Pass J.M., and Ping P. Scaffold proteins and assembly of multiprotein signaling complexes. J Mol Cell Cardiol 37 (2004) 391-397
88. Song C., Vondriska T.M., Wang G.W., Klein J.B., Cao X., Zhang J., et al. Molecular conformation dictates signaling module formation: example of PKCepsilon and Src tyrosine kinase. Am J Physiol Heart Circ Physiol 282 (2002) H1166-H1171